Related Experiment Video

Updated: Feb 5, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.6K

Inpatient Pediatric Epistaxis: Management and Resource Utilization

Jonathan S Ni1, Jocelyn Kohn2, Jessica R Levi1,2

  • 11 Boston University School of Medicine, Boston, Massachusetts, USA.

The Annals of Otology, Rhinology, and Laryngology
|September 6, 2018
PubMed

Insights

Pediatric epistaxis admissions incur significant charges despite rarely needing procedures or long hospital stays. Factors like admission source and household income influence costs, highlighting potential for improved resource use.

Area of Science:

  • Pediatric Healthcare
  • Health Economics
  • Medical Informatics

Background:

  • Epistaxis (nosebleeds) is common in children but rarely requires hospitalization.
  • Inpatient management of pediatric epistaxis is not well-studied due to its rarity.

Purpose of the Study:

  • Analyze national trends in pediatric epistaxis inpatient treatment.
  • Identify factors influencing total healthcare charges for these admissions.

Main Methods:

  • Utilized the 2012 Kids' Inpatient Database (KID) for weighted discharges with epistaxis as the primary diagnosis.
  • Collected data on demographics, comorbidities, treatments, and hospital burden.
  • Employed linear regression to analyze cost-influencing factors.

Main Results:

  • Analyzed 372 weighted discharges; mean age 9.68 years, 60% male.
  • Common comorbidities included thrombocytopenia, von Willebrand disease, and chronic sinusitis.
  • 56.7% of admissions did not undergo epistaxis control procedures; mean charges were $30,208.
  • Longer length of stay, emergency department admission, and higher household income predicted increased charges.
  • Midwest hospital region predicted decreased charges; procedures did not significantly impact cost.

Conclusions:

  • Pediatric epistaxis hospitalizations often do not necessitate lengthy stays or procedural interventions.
  • Substantial healthcare charges are associated with inpatient epistaxis treatment.
  • Understanding cost drivers can optimize resource allocation and management strategies.
Abstract

Keywords:
epistaxismanagementpediatricresource utilization

More Related Videos

Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry03:37

Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry

Published on: June 6, 2025

470
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

4.0K

Related Concept Videos

Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
586
Short-distance Transport of Resources02:12

Short-distance Transport of Resources

Short-distance transport refers to transport that occurs over a distance of just 2-3 cells, crossing the plasma membrane in the process. Small uncharged molecules, such as oxygen, carbon dioxide, and water, can diffuse across the plasma membrane on their own. In contrast, ions and larger molecules require the assistance of transport proteins due to their charge or size. Transport across membranes also occurs within individual cells, playing a variety of essential roles for the plant as a whole.
17.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Xylem and Transpiration-driven Transport of Resources02:03

Xylem and Transpiration-driven Transport of Resources

The xylem of vascular plants distributes water and dissolved minerals that are taken up by the roots to the rest of the plant. The cells that transport xylem sap are dead upon maturity, and the movement of xylem sap is a passive process.
26.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
314
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
236